Mentice Revenue and Competitors

Chicago, IL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Mentice's estimated annual revenue is currently $37.9M per year.(i)
  • Mentice's estimated revenue per employee is $251,000

Employee Data

  • Mentice has 151 Employees.(i)
  • Mentice grew their employee count by -1% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$55.7M2224%N/AN/A
#2
$12.3M49-11%N/AN/A
#3
$9.8M39-2%N/AN/A
#4
$3.8M15-29%N/AN/A
#5
$21.8M87-13%N/AN/A
#6
$38.9M155-9%N/AN/A
#7
$109.7M4373%N/AN/A
#8
$48.9M19526%N/AN/A
#9
$12450M385121%$1.7BN/A
#10
$10.8M43-10%N/AN/A
Add Company

Mentice is the world leader in virtual reality?based interventional medical simulation solutions. Our solutions help healthcare professionals with skills acquisition, continuous development and preprocedural planning—leading to improved productivity and outcomes. Mentice solutions are scientifically validated, and have been specifically developed for healthcare providers and the medical industry. Neurovascular, cardiovascular and peripheral interventions are just some of the areas covered by our systems.

keywords:N/A

N/A

Total Funding

151

Number of Employees

$37.9M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mentice News

2022-04-17 - Mentice's CEO Göran Malmberg to present the company's ...

STOCKHOLM, April 20, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with...

2022-04-17 - Why Mentice AB (publ) (STO:MNTC) Could Be Worth Watching

Great news for investors – Mentice is still trading at a fairly cheap price. According to my valuation, the intrinsic value for the stock is...

2022-03-30 - Virtual Reality in Medicine Market Will Generate Massive ...

Major Key Players of the Market: CAE, Immersivetouch, Mentice, Mimic Technologies, Simbionix, Surgical Theather, Virtamed, VR Simulators &...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.9M15126%N/A
#2
$29.9M15120%N/A
#3
$36.5M151-24%N/A
#4
$26.6M1511%N/A
#5
$38.9M151-6%N/A